Literature DB >> 25327443

Immunobiology of IL-37: mechanism of action and clinical perspectives.

Shannon Quirk1, Devendra K Agrawal.   

Abstract

This article provides an overview of the biological function of a recently discovered cytokine, IL-37, formerly referred to as IL-1F7, and its role in chronic inflammation and autoimmune disease. Much has been discovered about IL-37 in the past decade, including its ability to down-regulate systemic and local inflammation by lowering levels of pro-inflammatory molecules. Here, we critically review the published reports. Future research is necessary to understand the receptor-dependent effects of IL-37, its intracellular and extracellular functions in both normal and diseased states and its potential role as a biomarker and pharmacological target in human disease.

Entities:  

Keywords:  IL-37; adaptive immunity; autoimmune disease; inflammation; innate immunity

Mesh:

Substances:

Year:  2014        PMID: 25327443      PMCID: PMC4596230          DOI: 10.1586/1744666X.2014.971014

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  23 in total

1.  A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity.

Authors:  Philip Bufler; Tania Azam; Fabia Gamboni-Robertson; Leonid L Reznikov; Sanjay Kumar; Charles A Dinarello; Soo-Hyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-15       Impact factor: 11.205

2.  Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases.

Authors:  Mübeccel Akdis; Simone Burgler; Reto Crameri; Thomas Eiwegger; Hiroyuki Fujita; Enrique Gomez; Sven Klunker; Norbert Meyer; Liam O'Mahony; Oscar Palomares; Claudio Rhyner; Nadia Ouaked; Nadia Quaked; Anna Schaffartzik; Willem Van De Veen; Sabine Zeller; Maya Zimmermann; Cezmi A Akdis
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

3.  Interleukin 37 expression protects mice from colitis.

Authors:  Eóin N McNamee; Joanne C Masterson; Paul Jedlicka; Martine McManus; Almut Grenz; Colm B Collins; Marcel F Nold; Claudia Nold-Petry; Philip Bufler; Charles A Dinarello; Jesús Rivera-Nieves
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

4.  IL-1 family nomenclature.

Authors:  Charles Dinarello; William Arend; John Sims; Dirk Smith; Hal Blumberg; Luke O'Neill; Raphaela Goldbach-Mansky; Theresa Pizarro; H Hoffman; Philip Bufler; Marcel Nold; Pietro Ghezzi; Alberto Mantovani; Cecilia Garlanda; Diana Boraschi; Anna Rubartelli; Mihai Netea; Jos van der Meer; Leo Joosten; Tom Mandrup-Poulsen; Marc Donath; Eli Lewis; Josef Pfeilschifter; Michael Martin; Michael Kracht; H Muehl; Daniela Novick; Miodrag Lukic; Bruno Conti; Alan Solinger; Peyman Kelk; Kelk Peyman; Frank van de Veerdonk; Chiristopher Gabel
Journal:  Nat Immunol       Date:  2010-11       Impact factor: 25.606

5.  Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss.

Authors:  Alexander R Moschen; Clemens Molnar; Barbara Enrich; Sabine Geiger; Christoph F Ebenbichler; Herbert Tilg
Journal:  Mol Med       Date:  2011-03-02       Impact factor: 6.354

6.  Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.

Authors:  Sanjay Kumar; Charles R Hanning; Michael R Brigham-Burke; David J Rieman; Ruth Lehr; Sanjay Khandekar; Robert B Kirkpatrick; Gilbert F Scott; John C Lee; Frank J Lynch; Wentao Gao; Andrea Gambotto; Michael T Lotze
Journal:  Cytokine       Date:  2002-04-21       Impact factor: 3.861

7.  IL-37 is a fundamental inhibitor of innate immunity.

Authors:  Marcel F Nold; Claudia A Nold-Petry; Jarod A Zepp; Brent E Palmer; Philip Bufler; Charles A Dinarello
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

Review 8.  IL-37: a new anti-inflammatory cytokine of the IL-1 family.

Authors:  Diana Boraschi; Davide Lucchesi; Stefan Hainzl; Maria Leitner; Elisabeth Maier; Doris Mangelberger; Gertie J Oostingh; Tobias Pfaller; Claudia Pixner; Gernot Posselt; Paola Italiani; Marcel F Nold; Claudia A Nold-Petry; Philip Bufler; Charles A Dinarello
Journal:  Eur Cytokine Netw       Date:  2011-09       Impact factor: 3.450

9.  In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis.

Authors:  Ana-Maria Bulau; Michaela Fink; Christof Maucksch; Roland Kappler; Doris Mayr; Kai Wagner; Philip Bufler
Journal:  ScientificWorldJournal       Date:  2011-12-26

10.  The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines.

Authors:  Sheetal Sharma; Nicole Kulk; Marcel F Nold; Ralph Gräf; Soo-Hyun Kim; Dietrich Reinhardt; Charles A Dinarello; Philip Bufler
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.426

View more
  23 in total

1.  The increased T helper cells proliferation and inflammatory responses in patients with type 2 diabetes mellitus is suppressed by sitagliptin and vitamin D3 in vitro.

Authors:  Elham Mahabadi-Ashtiyani; Vida Sheikh; Shiva Borzouei; Iraj Salehi; Mahdi Alahgholi-Hajibehzad
Journal:  Inflamm Res       Date:  2019-06-25       Impact factor: 4.575

2.  Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation.

Authors:  Y Li; M Zhao; C Guo; H Chu; W Li; X Chen; X Wang; Y Li; Y Jia; S Koussatidjoa; F Zhu; J Wang; X Wang; Q Wang; W Zhao; Y Shi; W Chen; L Zhang
Journal:  Oncogene       Date:  2017-11-06       Impact factor: 9.867

3.  Beneficial effects of IL-37 after spinal cord injury in mice.

Authors:  Marina Coll-Miró; Isaac Francos-Quijorna; Eva Santos-Nogueira; Abel Torres-Espin; Philip Bufler; Charles A Dinarello; Rubèn López-Vales
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

Review 4.  The Role of IL-37 in Non-Cancerous Diseases.

Authors:  Vivi A Ding; Ziwen Zhu; Alyse A Mantz; Huaping Xiao; Mark R Wakefield; Qian Bai; Yujiang Fang
Journal:  Pathol Oncol Res       Date:  2016-10-27       Impact factor: 3.201

5.  IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1/NF-κB/MMP2 signal pathway.

Authors:  Xishuang Wang; Zengtao Wei; Zhongyun Tang; Chenyue Xue; Huayun Yu; Derui Zhang; Yulan Li; Xihong Liu; Yongyu Shi; Lining Zhang; Guoling Chen; Huaiyu Zhou; Jianing Wang; Xiaoyan Wang
Journal:  Lab Invest       Date:  2021-03-22       Impact factor: 5.662

Review 6.  Biology of interleukin-37 and its role in autoimmune diseases (Review).

Authors:  Huiqiong Zeng; Kaixia Zhou; Zhizhong Ye
Journal:  Exp Ther Med       Date:  2022-06-07       Impact factor: 2.751

7.  Common genetic heterogeneity of human interleukin-37 leads to functional variance.

Authors:  Jingjing Yan; Yuling Zhang; Shimeng Cheng; Bin Kang; Jinbiao Peng; Xiaodan Zhang; Meichun Yuan; Wenqi Chu; Wen Zhang; Jiayin Shen; Shuye Zhang
Journal:  Cell Mol Immunol       Date:  2016-09-26       Impact factor: 11.530

Review 8.  The role of IL-37 in cancer.

Authors:  Vivi A Ding; Ziwen Zhu; Huaping Xiao; Mark R Wakefield; Qian Bai; Yujiang Fang
Journal:  Med Oncol       Date:  2016-06-01       Impact factor: 3.064

Review 9.  The IL-1 cytokine family and its role in inflammation and fibrosis in the lung.

Authors:  L A Borthwick
Journal:  Semin Immunopathol       Date:  2016-03-21       Impact factor: 9.623

10.  Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.

Authors:  Xu Shuai; Li Wei-min; Ya-lin Tong; Ning Dong; Zhi-yong Sheng; Yong-ming Yao
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.